Role of ACE inhibitors in uncomplicated essential hypertension J I S Robertson
The design and early development of drugs which inhibited angiotensin converting enzyme (ACE inhibitors) was conducted with the expectation that the principal applications of such agents would lie in clinical syndromes in which the activity of the renin-angiotensin system was enhanced-for example, renovascular hypertension and certain varieties of cardiac failure. With the introduction of the first orally active ACE inhibitor, captopril, it quickly became apparent, however, that such treatment was applicable to essential (primary) hypertension, in which both the antihypertensive efficacy and the acceptability of ACE inhibitors were found to be at least comparable with those of other drug classes. The use of ACE inhibitors, either given alone or in combination with other drugs, in uncomplicated essential hypertension now constitutes a major indication and has appreciably increased therapeutic freedom. Even so, there remains a remarkable reluctance on the part of some authorities to endorse the use of ACE inhibitors as initial (so-called "first line") treatment in essential hypertension.' 2 I consider this seemingly strange anomaly later in this article. Probably because of their effect in slowing heart rate, [ blockers are liable to have a modest capacity to lower systolic pressure.32 33 Systolic blood pressure reduction has, perhaps not surprisingly therefore, been found to be greater with lisinopril than metoprolol24 or atenolol.'9 Even so, enalapril was seen also to lower systolic pressure more than did hydrochlorothiazide. ' group.bmj.com on June 20, 2017 -Published by http://heart.bmj.com/ Downloaded from unnecessary in this combination; indeed, in patients with renal impairment, which may be occult in elderly subjects, dangerous hyperkalaemia might be provoked by their use. A further theoretical gain with the addition of ACE inhibitor to thiazide or loop acting diuretic is that raised plasma potassium concentrations could enhance the antihypertensive effect. 43 Mechanism of antihypertensive effect of ACE inhibitors The necessarily appropriate acknowledgement that the mechanism or mechanisms of the antihypertensive action of ACE inhibitors is imperfectly understood is to recognise a similarity with other widely used drug classes such as thiazides and 1 blockers, for which, likewise, the mode of action remains partly obscure.
The immediate effect of the administration of ACE inhibitor is a reduction in peripheral plasma angiotensin II concentration, with a proportionate acute fall in blood pressure. With continued administration of an ACE inhibitor, however, a further substantial fall in arterial pressure usually occurs in essential hypertension. Several mechanisms have been proposed to explain this progressive antihypertensive effect. These are not mutually exclusive; all are currently speculative.
The existence of numerous local tissue renin-angiotensin systems is well established. Inhibition of these might, in several ways, contribute to lowering of arterial pressure. Among these, an especially attractive theory is that ACE inhibition reverses the broadly "trophic" action of angiotensin II on the medial smooth muscle of resistance arteries; reversal of this trophic effect causes regression of the medial thickening, and hence enhancement of blood pressure reduction. 6 
Inhibition of the formation of angiotensin II, both within the circulation and locally in the brain, will diminish sympathetic nervous discharge.63 Such an effect has been clearly shown in certain clinical circumstances, notably cardiac failure.64 65 A similar action should contribute to blood pressure reduction in essential hypertension.
Diminution of circulating concentrations of angiotensin II lowers the rate of aldosterone secretion. Among the consequences of this is raised plasma potassium concentration, which is likely to contribute, albeit modestly, to the antihypertensive effect. 43 Another The vexed question of whether modestly raised plasma renin, and hence raised angiotensin II concentrations, carries a specific adverse prognosis in essential hypertension remains unresolved. (Undoubtedly, markedly raised plasma concentrations of angiotensin II can cause myocardial necrotic lesions, arterial damage, and renal tubular necrosis.73) The original proposal, that modestly raised plasma renin activity in essential hypertension predisposes to stroke and myocardial infarction, has been abandoned. In a later prospective study, Alderman et al found that hypertensive subjects with raised plasma renin activity were more likely than those with lower renin activities to suffer myocardial infarction, but not stroke. 74 The analysis was, however, based on few events and was not confirmed by the large study of Meade et al. 75 Most relevant is that the results were insufficiently impressive to deter Alderman from subsequently advocating thiazide diuretics, which raise plasma renin and angiotensin II values, as first treatment in hypertension.76 Thus these aspects cannot at present be convincingly invoked in favour of the early use of ACE inhibitors in essential hypertension.
Quality of life
Early open studies, in which ACE inhibitors were given to patients with poorly controlled hypertension, raised the possibility, not wholly welcome, that these drugs might possess a euphoriant effect,77 perhaps because of central inhibition of enkephalinase. Closer critical evaluation suggested, however, that a more likely explanation was that the ACE inhibitor was giving relief from the unpleasant symptoms associated with other drugs.
RESULTS OF STUDIES
In a double blind study Callender et al found a slight but significant depression of mood when captopril was substituted for placebo.78 Dahlof et ACE inhibitors do not usually have major adverse effects on the quality of life. They seem to be distinctly superior to methyldopa and propranolol and probably also nifedipine. There is no good evidence of long term superiority over atenolol. A suggestion that captopril is more acceptable than enalapril has been questioned. ACE inhibitors do not have a euphoriant effect. There is no good evidence that ACE inhibitors cause sexual problems.
Side effects As Fletcher and Dollery have emphasised,77 side effects associated with ACE inhibitors can be placed into four principal groups: effects related to the main pharmacological action (hypotension, bradycardia, renal impairment); effects connected with subsidiary actions (enhancement of kinins, inhibition of enkephalinase); idiosyncratic class effects (cough, angioneurotic oedema, Raynaud's phenomenon); and compound specific (mainly captopril) effects (proteinuria, the nephrotic syndrome, taste disturbance, rash, and perhaps Guillain-Barre neuropathy).
FIRST DOSE HYPOTENSION ACE inhibition will cause an initial acute fall in arterial pressure, in proportion to the prevailing peripheral plasma concentration of angiotensin II. This is unlikely to cause problems with the introduction of an ACE inhibitor in previously untreated essential hypertension, when plasma renin and hence angiotensin II concentration are likely to be normal or low. Caution is needed if previous treatment, such as diuretics, has raised angiotensin II concentrations. Severe first dose hypotension, endangering cerebral and renal blood flow, can readily occur in these circumstances. 90 Whenever possible, such antecedent treatment should be withdrawn for a few days before starting ACE inhibition. Otherwise, the ACE inhibitor should be introduced under strict supervision, with facilities (such as angiotensin II for infusion) available for resuscitation as necessary.
First dose hypotension is not necessarily a sole consequence of acute loss of the arterial constrictor effect of angiotensin II. Contributions may also come from loss of angiotensin mediated sympathetic enhancement and vagal inhibition, when bradycardia can be an added hazard. However, these additional problems (which may call for the administration of atropine) are more likely in heart failure treated by diuretics and digoxin than in essential hypertension.9" First dose hypotension has also been asserted to occur independently of the prevailing angiotensin II concentration in elderly subjects with essential hypertension, although this is not well substantiated. Elderly subjects are, nevertheless, likely to tolerate hypotension poorly.
RENAL IMPAIRMENT
Renal functional deterioration is not likely with the use of ACE inhibitors in uncomplicated essential hypertension. More usually it stems from loss of angiotensin II mediated sustenance of renal function in circumstances of impaired renal blood flowfor example, cardiac failure or renal artery stenosis.92 Occult renal artery stenosis in patients with apparent essential hypertension can cause problems; it is more prevalent in elderly subjects and in those with evident arterial disease at other sites.
HYPERKALAEMIA
Hyperkalaemia occurs with ACE inhibitors only if they are given incorrectly, with potassium conserving agents, or to patients with renal impairment.
SINUS TACHYCARDIA
Sinus tachycardia, which can persist, is an unusual, but real, problem, most often occurring with concomitant diuretic and ACE inhibition.93 COUGH That ACE inhibitors can provoke dry cough has been known since the paper of Havelka et al in 1982. 94 The reported prevalence of this side effect varies widely, from less than 1% up to 22%.77 The problem seems common to all currently used clinical ACE inhibitors.
The cough is associated with increased sensitivity of the cough reflex. Some, but not all, asthmatic subjects seem to be especially susceptible. Although the mechanism is not known, an increase in tissue kinin may be contributory. ANGIONEUROTIC OEDEMA Angioneurotic oedema, which can affect the lips, tongue, glottis, mouth, or larynx, can be life threatening. It affects some 0.2% of patients and seems to be independent of the individual ACE inhibitor used. Most cases occur in the first week of treatment, and these are potentially the most serious. 77 With angioneurotic oedema ACE inhibition should be stopped. Most instances resolve spontaneously; there has been a suggestion that addition of antihistamines can be helpful.
If the tongue, glottis, or larynx are affected to an extent that the airways are obstructed subcutaneous adrenaline solution (1: 1000 (3-5 ml)) should be given at once. 
